北米の更年期障害治療市場 – 業界動向と2030年までの予測

北米の更年期障害治療市場の分析と規模

近年、市場は2023年から2030年の予測期間中に急速に成長すると予測されています。更年期障害は、世界中の製薬会社が更年期障害やそれに伴う問題を治療するための効果的な薬を開発する大きな動機となっています。閉経後女性の約85％が生涯に一度は更年期障害の症状を経験しており、血管運動症状だけでも米国では約4,000万から5,000万人の女性に発症すると予想されています。更年期障害は世界中でますます蔓延しており、多くのヘルスケア組織が更年期障害を効果的に治療できる薬の開発と使用をサポートしています。

データブリッジ市場調査は、2023年から2030年の予測期間における更年期障害治療市場の成長率を分析しています。更年期障害治療市場の予想CAGRは、上記の予測期間中に約7.6％になる傾向があります。市場価値は2022年に59億5,740万米ドルで、2030年までに107億420万米ドルまで成長すると予想されています。市場価値、成長率、市場セグメント、地理的範囲、市場プレーヤー、市場シナリオなどの市場洞察に加えて、データブリッジ市場調査チームがまとめた市場レポートには、詳細な専門家分析、患者疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

北米の更年期障害治療市場の範囲とセグメンテーション

Market Definition

Menopause is a natural biological process which occurs due to the reduction of reproductive hormones. This marks the end of the menstrual cycle. It usually occurs in the late 40s or 50s. The menopause symptoms occur differently for every women. It has been noticed that the estrogen levels decline throughout menopause. Many women witness symptoms such as night sweats, vaginal dryness, hot flashes while some face abnormal menstrual cycles, difficulty sleeping, mood swings, and others.

North America Menopausal Disorder Treatment Market Dynamics

Drivers

• Increasing Demand of Herbal Treatments

With each passing decade, women are inclining more towards herbal supplements for their menopause treatment which is one of the market's most significant latest developments. As a result, numerous companies are responding to the market need by manufacturing latest products which contain menopause-relieving components. For instance, soy isoflavones and  black cohosh are the two natural remedies that work well for menopause. Thus, this new concept is increasing the market growth rapidly.

• Increased Drug Development Processes

An increase in the number of menopausal drugs in the drug development pipeline of several major manufacturers is one of the huge opportunities for the growth of the market. It includes specific and innovative drugs that primarily focus on decreasing side effects and providing improved efficacy. For instance, The first and only body-identical hormone replacement therapy (HRT) for oestrogen insufficiency symptoms in postmenopausal women with an intact uterus and at least a year post their last period, Bijuva, also called as Bijuve in the U.K., which includes estradiol and progesterone in a single daily oral capsule. Thus, this boosts the market growth.

 Opportunities

• Major Impact of Trending Lifestyle and Stress

In recent years, it has become positively important to provide women with much effective therapy for menopause symptoms because of the rise in the occurrence of physical and mental health issues among women. Factors such as migraine, anxiety, irritability, formication, fatigue, hot flashes, mood swings, and insomnia led many companies to develop high-end therapies to improve these symptoms. Huge growth in the menopause therapy industry is being aided by widespread investments in extended R&D initiatives to launch novel medications. This factor is helping the market growth in a great way.

• Increasing Demand of Oral Drugs

Oral drugs are one of the easiest, most durable, affordable, and most portable mode of administration. It has been observed that the rate of contamination is also very minimum. This makes this route of administration more beneficial. The oral mode of administration is found to be beneficial especially for the elderly population who suffers from this disorder frequently. Thus, this factor enhances the growth of the market.

Restraints/Challenges

• Growing Underlying Disparities Between Genders

Numerous companies providing multiple treatments for menopause have struggled considerably due to the existence of major gender-wise health disparities in many countries. Women in several countries with limited awareness and income see no gains in their health due to the lack of adequate healthcare infrastructure. This acts as a major restriction for the market.  

• Side Effects of Hormone Therapy

According to the FDA, numerous complications associated with hormone therapy carry various hazards, including the possibility of heart problems, stroke, blood clots, and breast cancer. Thus, it hampers the market growth.   

This menopausal disorder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the menopausal disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Menopausal disorder Treatment Market

The menopausal disorder treatment market is segmented on the basis of stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Stages

• Menopause
• Postmenopause
• Perimenopause

Type

• Hormonal Therapy
• Non-Hormonal Therapy

Menopause Symptoms

• Vasomotor Symptoms
• Atrophic Vaginitis
• Osteoporosis
• Joint Pain
• Weight Gain
• Dyspareunia
• Depression
• Others

Dosage Form

• Tablet
• Cream

• Gels
• Rings/Insert
• Patch/Film
• Injection Shot
• Spray
• Others

Route of Administration

• Oral
• Vaginal
• Transdermal
• Parenteral

End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

North America Menopausal Disorder Treatment Market Regional Analysis/Insights

The menopausal disorder treatment market is analyzed and market size insights and trends are provided by stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel as referenced above.

The major countries covered in the menopausal disorder treatment market report are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Belgium.

Germany is leading the menopausal disorder treatment market due to the growing demand of many effective treatments such as hormone replacement therapy. Also, the country witnessed advanced medical environment that has resulted in the world's lowest cancer mortality rates, a life expectancy for people over 80 years that is actually more compared to other regions, and minimized heart attack and stroke death rates than those in similar countries. Thus, all these factors led to the market growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and North America Menopausal Disorder Treatment Market Share Analysis

The menopausal disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to menopausal disorder treatment market.

更年期障害治療市場で活動している主要企業は次のとおりです。

• F.ホフマン・ラ・ロシュ社（スイス）
• マイランNV（米国）
• テバ製薬工業株式会社（イスラエル）
• サノフィ（フランス）、ファイザー（米国）
• GSK plc（英国）
• ノバルティスAG（スイス）
• アストラゼネカ（英国）
• ジョンソン・エンド・ジョンソン プライベート・リミテッド（米国）
• メルク社（米国）
• イーライリリー・アンド・カンパニー（米国）
• アボット（米国）
• ノボ ノルディスク A/S (デンマーク)
• アッヴィ社（米国）
• ドクター・レディーズ・ラボラトリーズ社（インド）
• セラピューティクスMD社（米国）
• イプセンファーマ（フランス）
• ベシンヘルスケア（ベルギー）
• ミスラ製薬（ベルギー）
• Aché Laboratorios Farmacêuticos SA (ブラジル)
• セベラ製薬（米国）
• ファーベント・ファーマシューティカルズ社（米国）
• KaNDy Therapeutics（英国）
• ダッシェネイ USA (米国) 

SKU-56618